Press Release

14
Sep

Ichor meets $18,000 crowd-funding goal in just 7 days

Syracuse, NY: Ichor Therapeutics, Inc., a pre-clinical biotechnology company that develops technologies to target age-related pathology, announced today that its first crowd-funding campaign has met its $18,000 goal in only 7 days. These funds will be used to study the effects of c60, a potent antioxidant, on human cancer proliferation. Longecity.org and a private donor pledged two dollars in additional

Read more

9
Sep

Ichor Therapeutics, Inc. launches online store

Syracuse, NY: Today, Ichor Therapeutics. Inc, a pre-clinical biotechnology company that develops technologies to target age-related pathology, announced the formation of WeCellStuff.com. The store features numerous research products and also provides local researchers with affordable access to capital assets, such as liquid handling robots and a flow cytometer, among others. Ichor CEO Kelsey Moody stated, “The use of core infrastructure

Read more

2
Sep

Ichor crowd-funding initiative to receive matching contributions

Syracuse, NY: Ichor Therapeutics, Inc., a pre-clinical biotechnology company that develops technologies to target age-related pathology, announced today the initiation of its first crowd-funding campaign. The company aims to raise at least $19,500 to study the effects of c60, a potent antioxidant, on human cancer proliferation. Longecity.org and a private donor have pledged two dollars in additional contributions for every

Read more

1
Aug

Ichor Therapeutics, Inc. raises $383,000 for contract research from BioSenex, Ltd.

Syracuse, NY: Ichor Therapeutics, Inc., a pre-clinical biotechnology company that develops technologies to target age-related pathology, announced today that it has raised $383,000 for contract research from BioSenex, Ltd. BioSenex is a new venture that aims to develop supplement-based formulations to treat chronic disease. BioSenex will also enter as a contender for the Rejuvenation Mprize, a multi-million dollar competition to

Read more